← Latest papers
📄 bioengineering

Cell-specific heteroclinic orbits govern interaction dynamics in inertial microfluidics for circulating tumour cell separation

This study demonstrates that incorporating cell-specific heteroclinic orbits and mechanical heterogeneity, rather than relying solely on size-based separation, is crucial for optimizing inertial microfluidic devices to minimize white blood cell carryover during circulating tumour cell isolation.

Original authors: Hay, R., Ghera, C., Zhou, J., Papautsky, I., Krueger, T., Owen, B.

Published 2026-09-17
📖 5 min read🧠 Deep dive

Original authors: Hay, R., Ghera, C., Zhou, J., Papautsky, I., Krueger, T., Owen, B.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Every year, cancer claims millions of lives, often because it is discovered only after symptoms appear and the disease has advanced. To catch these illnesses earlier, doctors look for circulating tumour cells: tiny fragments of a tumour that break away and travel through the bloodstream. Finding these rare cells in a sample of blood could provide a crucial early warning, but the task is incredibly difficult. Blood is a crowded river of white blood cells, and the tumour cells are scarce, often appearing at concentrations of just five to one hundred cells in every millilitre. To separate them, scientists use microfluidic devices, which are tiny channels that guide cells using the physics of fluid flow. These devices rely on a simple principle: larger cells tend to move differently than smaller ones, allowing them to be sorted into different streams. However, this method is not perfect. Even with careful design, unwanted white blood cells often slip into the stream meant for the tumour cells, contaminating the sample and making analysis harder.

Researchers have long assumed that the key to better separation lies in the size difference between the cells. They believed that if they could simply make the tumour cells move faster toward the target stream than the white blood cells, the job would be done. But a new study suggests that this view is incomplete. By simulating the movement of cells in a straight microchannel, scientists discovered that the physical "squishiness" of the cells plays a massive role in how they interact. When a tumour cell and a white blood cell are close to each other, they do not just pass by independently; they influence one another. The study found that the way these cells deform as they flow changes the paths they take, and this interaction can drag unwanted white blood cells into the wrong stream, ruining the separation.

The researchers used a powerful computer simulation to watch how these cells behave in a channel that is only fifty micrometres high and one hundred and fifty micrometres wide. They modeled the cells as flexible, balloon-like spheres filled with fluid, similar to how real cells behave. In their simulations, they placed one tumour cell and eight white blood cells into the channel and watched them travel downstream. They tested different levels of stiffness, or deformability, for the tumour cells, ranging from very soft to quite stiff, while keeping the white blood cells relatively stiff. The goal was to see if the tumour cell's flexibility changed how the white blood cells moved.

The results showed that the presence of a tumour cell significantly altered the path of the white blood cells. When the tumour cell was very soft, the white blood cells stayed mostly on their own paths. But when the tumour cell was stiffer, the white blood cells were more likely to be pulled off course. The researchers observed two distinct types of interactions. In a "short" interaction, the cells would pass each other quickly, causing a brief jolt that might push a white blood cell slightly toward the target stream or back toward the wall. These quick encounters were frequent but did not cause a major shift in the overall flow.

However, a different scenario emerged when the tumour cell and a white blood cell had similar stiffness. In these cases, the two cells would get close and stay close for a long time, moving together at nearly the same speed. The researchers called this a "long" interaction. During these prolonged encounters, the white blood cell would drift away from its usual path and travel alongside the tumour cell, often ending up in the target stream where it did not belong. This happened because the two cells were following very similar routes through the channel, allowing them to stay in each other's wake for a long distance.

The study revealed that the distance between the natural paths of the two cell types is the deciding factor. When the tumour cell was very soft, its natural path was far away from the path of the stiffer white blood cells, so they rarely stayed close enough to interact for long. But when the tumour cell was stiffer, its path moved closer to the path of the white blood cells. This proximity made it much more likely for the two cells to get stuck in a long interaction, dragging the white blood cell into the target stream. The researchers found that the stiffer the tumour cell, the more likely it was to pull a white blood cell along with it.

This finding challenges the idea that size is the only thing that matters in these devices. The researchers suggest that the mechanical properties of the cells, specifically how easily they can be squashed, are just as important as their size. In the real world, cancer cells are not all the same; some are very soft, while others, especially those from early-stage cancers, can be quite stiff. If a device is designed only to separate based on size, it might fail to catch the stiff, early-stage tumour cells because they will interact too much with the white blood cells and get lost in the mix.

The team concluded that to build better devices, engineers need to think about more than just the size of the cells. They need to consider how the cells' stiffness affects their paths and how those paths bring the cells together. By understanding these interactions, designers might be able to adjust the flow or the shape of the channel to keep the paths of the tumour cells and white blood cells far enough apart that they do not get stuck together. This could lead to cleaner samples and a better chance of detecting cancer at its earliest, most treatable stages. The work does not offer a finished solution, but it provides a clear map of a hidden problem that has been overlooked, showing that the way cells move together is just as critical as the way they move alone.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →